Clinical Trial Update: Enhancing Recovery in Early Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in schizophrenia sponsored by the Central Institute of Mental Health Mannheim is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Schizophrenia | Phase 2 | Status: ACTIVE_NOT_RECRUITING